Form S-8 NEUROCRINE BIOSCIENCES
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Neurocrine Bio. (NBIX) PT Raised to $158 at Citi
August 1, 2024 3:55 PM EDTCiti analyst David Hoang raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $158.00 (from $150.00) while maintaining a Neutral rating.
The analyst comments "NBIX reported 2Q24 results and corporate updates. Ingrezza surprised with a healthy beat ~$40M above consensus and ~$50M above our... More
